Atlas Venture Associates XI, LP

Track

Insider profile

Atlas Venture Associates XI, LP's trades of Dyne Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
20.02
Quantity 1,413
Value US$28,288
Transaction date
Proposed sale
Price
20.41
Quantity 1,401
Value US$28,594
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-07 2026-07-07
PrS Proposed sale
10,611
74.24
US$996,610 		10,611 74.24 US$996,610
2026-07-07 2026-07-07
PrS Proposed sale
39,013
495.15
US$859,322 		39,013 495.15 US$859,322
2026-05-06 2026-05-06
PrS Proposed sale
76,104
138.28
US$3,756,531 		76,104 138.28 US$3,756,531
2026-05-05 2026-05-05
PrS Proposed sale
60
17.71
US$1,063 		60 17.71 US$1,063
2026-05-04 2026-04-29
PrS Proposed sale
61
17.39
US$1,061 		61 17.39 US$1,061
2026-04-28 2026-04-28
PrS Proposed sale
1,171
18.04
US$21,125 		1,171 18.04 US$21,125
2026-04-27 2026-04-27
PrS Proposed sale
894
18.26
US$16,324 		894 18.26 US$16,324
2026-04-24 2026-04-24
PrS Proposed sale
710
18.90
US$13,419 		710 18.90 US$13,419
2026-04-23 2026-04-23
PrS Proposed sale
377
19.67
US$7,416 		377 19.67 US$7,416
2026-04-22 2026-04-22
PrS Proposed sale
1,485
19.21
US$28,527 		1,485 19.21 US$28,527
2026-04-21 2026-04-21
PrS Proposed sale
1,413
20.02
US$28,288 		1,413 20.02 US$28,288
2026-04-20 2026-04-20
PrS Proposed sale
1,401
20.41
US$28,594 		1,401 20.41 US$28,594